RedHill Biopharma Ltd. - RDHL

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$260K
QoQ value delta ($000)
-$5K (-1.89%)
Implied price effect (QoQ)
+0.23%
Shares
Total shares
309,152
QoQ shares delta
-6,666 (-2.11%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (RDHL)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Yorkville Advisors Global, LP 106 122,131 0.12%
GAGNON SECURITIES LLC 74 88,405 0.01%
CITADEL ADVISORS LLC 55 65,321 0.0%
RHUMBLINE ADVISERS 11 13,755 0.0%
Lido Advisors, LLC 9 11,009 0.0%
CITIGROUP INC 3 4,378 0.0%
Federation des caisses Desjardins du Quebec 2 3,388 0.0%
MORGAN STANLEY 0 1 0.0%
ROYAL BANK OF CANADA 0 351 0.0%
UBS Group AG 0 100 0.0%
SBI Securities Co., Ltd. 0 21 0.0%
GAMMA Investing LLC 0 287 0.0%
Smartleaf Asset Management LLC 0 5 0.0%